Apply for the Sunrise Alzheimer's Disease study

A clinical trial near you is evaluating an investigational medication to determine if it is safe and effective in reducing agitation symptoms in patients with Alzheimer’s Disease.

  • Drug IP

    Joining a clinical trial may provide options.

  • SAN-PHY-001 - Right Side List Logo Media

    Potential to advance medical research for Alzheimer’s Disease.

  • Money

    You may get reimbursed for study-required travel.

What is the purpose of the study?

Agitation, among other symptoms associated with Alzheimer's Disease, can be difficult to manage. This clinical trial, Sunrise, is investigating a study medication to determine if it is safe and effective in reducing agitation symptoms in patients with Alzheimer's Disease.

Download a PDF of the study details.

Study Overview

The Sunrise Alzheimer's Disease study is seeking participants for a trial to assess an investigational medication for adults (ages 55-85). An individual may be eligible if they have been diagnosed with Alzheimer’s Disease and experience certain agitation symptoms, such as restlessness, yelling, or resistance. A study partner (caregiver) is also required as part of this study. The study partner will attend each study visit with the participant.

Clinical trial studies are critical in helping medical researchers develop investigational medications for patients with Alzheimer’s Disease. If you know someone who is affected by Alzheimer's Disease and might be interested in this study, complete our short online questionnaire.

TrialSpark helps to connect individuals that are looking for clinical trial options with clinical research sites. If the person you know qualifies, they will have the option to schedule a brief call with a study team member to discuss their eligibility. We are here to help patients learn about what's involved in clinical trials and study participation.

How to See If Someone Qualifies

  1. See If They May Qualify

    Complete a short (<10 min) questionnaire to see if someone you know may be eligible for this study. The information you provide is securely stored and encrypted under HIPAA.

  2. Speak to a Nurse Enrollment Specialist

    If someone you know may qualify, you'll schedule a ~30 minute call with a nurse at a time that's convenient. The nurse will address any questions and confirm the patient’s possible eligibility.

  3. Schedule with the Study Doctor

    Based on the call and medical history, if a patient is eligible and interested in participating, they’ll be connected with a nearby research site for a possible in-person screening visit.

Why Participate?

  • Joining a clinical trial may provide options.

    There are currently no approved treatments in the US for treating agitation symptoms associated with Alzheimer's Disease.

  • Visit with board-certified physicians.

    All study-related medications, analysis, procedures, and clinic visits with study doctors will be provided at no cost to you or your insurance company.

  • Potential to advance Alzheimer’s Disease research.

    Clinical trials may help you better understand Alzheimer’s Disease and help inform the development of future treatments for the condition.

  • Possibly get reimbursed for your study-required travel.

    Travel costs to study visits may be reimbursable. You can discuss support and stipends with study staff.

Potential Risks

There may be side effects associated with taking the investigational medication. The study doctor will discuss all potential risks and side effects, both known and the potential for unknown, with you during an in-person screening visit.

What to Expect In The Study

  1. Screening (4 weeks) A potential research volunteer will have the opportunity to review the consent document fully to make an educated decision about whether to participate in the trial. Upon consent, the study doctor will perform assessments to confirm that a patient is eligible to participate. Enrolled participants will be randomly assigned either the investigational medication or the placebo.

  2. Study Treatment Period (6 weeks) The study medication being investigated is an oral medication taken every night to see if it potentially reduces agitation symptoms in individuals with Alzheimer's Disease. To monitor safety and study progress, certain study visits will include: collecting medical history information, physician exams, behavioral / psychiatric questionnaires, blood draws, and electrocardiograms (ECGs).

  3. Follow-up (2 weeks) After treatment ends, the study doctor will continue to follow up with the participant. During the last visit of the follow-up period, the participant's safety will be thoroughly monitored and evaluated.

7 visits

There are 7 total study visits, 6 in person and 1 remote. Of the 6 in person visits, 2 can also be conducted remotely if preferred.

12 weeks

The 7 study visits will be scheduled over a period of about 12 weeks.

1x / night

The study medication is an oral medication that will be taken once daily at bedtime.

Explore research options for Alzheimer's Disease.

Express your interest in a clinical trial today.